About Daymark Health
Daymark Health is a private company based in Philadelphia, Pennsylvania, incorporated in 2022 in Delaware. It has reported $37,500,027 raised in three offerings on Form D since August 2024. Its chief executive is Justin Bekelman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2025 | Sep 3, 2025 | $26,000,000fully sold | 7 | $3.7M | EquityRule 506(b) | Form D ↗ |
| Mar 4, 2025 | Mar 14, 2025 | $6,000,000fully sold | 2 | $3.0M | Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D ↗ |
| Aug 1, 2024 | Aug 26, 2024 | $5,500,027fully sold | 3 | $1.8M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $37,500,027 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Daymark Health's Form D filed Sep 3, 2025.
Earlier filings also listed Matthew Bettonville (director, last listed Mar 2025), Alon Krashinsky (secretary, treasurer, cfo and director, last listed Mar 2025), Robert Pahlavan (director, last listed Aug 2024), Paul Default (chief operating officer, last listed Aug 2024), Jonathan Rhodes (director, last listed Aug 2024) and Brian Lovett (director, last listed Aug 2024).